Hmm, goes to show that the poor press around tamiflu stockpiling/effectiveness has hit home. The saving grace is Japan, along with data collected to date. If they prove effectiveness in complications it will be absolutely key for work to continue. If data doesn't help, then this may be the end of free funding.
Add to My Watchlist
What is My Watchlist?